Race to save newborns: trial tests new Heart-Restart drug
NCT ID NCT05738148
Summary
This study aims to find out if a medication called vasopressin works better than the current standard drug, epinephrine, to restart the heart in newborns who need emergency CPR at birth. The hospital will use one drug or the other for a year, and researchers will compare how quickly the babies' heartbeats return. The goal is to see if vasopressin leads to faster recovery and better survival for these critically ill infants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST NEONATAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Alexandra Hospital
RECRUITINGEdmonton, Alberta, T5H 3V9, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.